Lithium Treatment for Bipolar Disorder Reduces the Risk of Rehospitalization

Researchers reveal that lithium treatment for patients suffering from bipolar disorder can lower the risk of rehospitalization, according to a study conducted on February 28, 2018.

Depression and elevated mood are the characteristics of bipolar disorder and treatment for this can be done by mood stabilizing or by using antipsychotic drugs. One of the most effective mood stabilizer is lithium, however, the long-term effects of different drugs used in the treatment of bipolar disorder has been compared by very few studies.

18,000 patients were involved in the study to compare the risk of rehospitalization. After a follow-up of over seven years, lowest risk of rehospitalization was observed in the treatment which used lithium. Compared to no treatment, 30 percent reduction in risk was observed in lithium treatment. When patients were treated using the long-acting injections instead of the oral medicines, a 30 percent lower risk of re-admission was observed in the patients. Only a 7 percent reduction in risk was observed by using quetiapine, which is an antipsychotic drug.

In recent years, lithium is the least preferred medicine for the treatment of bipolar disorder. However, this study shows that primary treatment for bipolar disorder must be by using lithium. Patients who find lithium as unsuitable for them, can go for long-acting injections, which are safer and effective as well. For this study, funding has been received by the authors from few pharmaceutical companies. The Finnish Ministry of Social Affairs and Health funded this research.

This method of using lithium for the treatment of bipolar disorder will increase the growth of anti-psychotic drugs market, as elaborated in the anti-psychotic drugs market report published by Coherent Market Insights.

You may be interested

Machine Learning-Based Smartphone App to Evaluate Parkinson’s Symptoms
Information Technology and Gadgets
Information Technology and Gadgets

Machine Learning-Based Smartphone App to Evaluate Parkinson’s Symptoms

Mohit Joshi - September 21, 2018

New smartphone app HopkinsPD, utilizes the smartphone's microphone, touchscreen, and accelerometer to examine patients for symptoms while they perform daily tasks Parkinson’s affects central nervous system of…

Depressive Thoughts Affect Working Memory
Healthcare
Healthcare

Depressive Thoughts Affect Working Memory

Mohit Joshi - September 20, 2018

Researchers establish a link between prolonged depression and reduced working memory, according to a new study published in March 2018. Researchers reveal that dysphoria, which is a…

Myeloproliferative Neoplasms Treatment Market – Current Trends and Future Opportunities by 2026
Healthcare
Healthcare

Myeloproliferative Neoplasms Treatment Market – Current Trends and Future Opportunities by 2026

Albert R - September 20, 2018

Coherent Market Insights added Latest Research Report titled “Myeloproliferative Neoplasms Treatment Market Insights by Manufacturers, Growth, Trends, Regions, Product Type and Application, Geography, Forecast to 2026” to…

Most from this category